Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Restricting Access to Mail-Service Pharmacies Increases Prescription Drug Costs for New York Consumers, Employers, Unions

March 24, 2011 By Bio-Medicine.Org

WASHINGTON, March 24, 2011 /PRNewswire-USNewswire/ — The New
York State Senate’s budget includes a legislative proposal that
would take away private and public sector payers’ ability to
provide lower cost home delivery options for chronic medications,
the Pharmaceutical Care Management Association (PCMA) said
today.

“Everyone knows that mail-service pharmacies make prescriptions
more affordable for consumers, employers, and unions,” said PCMA
President and CEO Mark Merritt
. “This proposal would enrich
independent drugstores at the expense of patients and put New York
in an even deeper budgetary hole than it is already in.”

Home delivery of prescription medications is a benefit for
consumers who appreciate the added convenience and access to
private counseling from a trained clinician seven days a week, 24
hours a day. Numerous government and peer-reviewed studies have
confirmed that mail-service pharmacies lower costs for consumers
and payers, make far fewer errors, and increase medication
adherence for those suffering from chronic conditions.

  • U.S. Government Accountability
    Office
    (GAO): In January
    2003, the GAO examined the value provided by PBMs participating in
    the federal employees’ health plan. For prescription drugs
    dispensed through mail-order pharmacies, the average mail-order
    price was about 27 percent below the average cash-price paid by
    consumers for a brand name at a retail pharmacy and 53 percent
    below the average cash-price paid for generic drugs.
  • The Federal Trade Commission (FTC): The FTC
    concluded in a 2005 report that PBM-owned mail-order pharmacies
    offer lower prices on prescription drugs than retail pharmacies and
    are very effective at capitalizing on opportunities to dispense
    generic medications.
  • Pharmacotherapy: Official Journal of the American College
    of Clinical Pharmacy
    :<

    ‘/>”/>

SOURCE

Related Articles Read More >

The most innovative medical devices of 2026
An illustration showing Corcym's Memo 4D Curve's laser-cut nitinol core.
Laser-cut nitinol and a layered design let these cardiac implants flex
Reconstructed 3D fluorescence image of the stained biohybrid mesh-tissue integration. The red, green, and blue colors correspond to the mesh, F-actin, and nuclei, respectively.
Researchers mesh electronics with human cells to develop living battery
A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe